Ensysce Biosciences (ENSC)
US Market

Ensysce Biosciences (ENSC) Income Statement


Ensysce Biosciences Income Statement

Last quarter (Q2 2023), Ensysce Biosciences's total revenue was $490.47K, an increase of Infinity% from the same quarter last year. In Q2, Ensysce Biosciences's net income was $-2.24M. See Ensysce Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21
Total Revenue
$ 2.71M$ 2.52M$ 0.00
Cost of Revenue
Gross Profit
$ 4.03M$ 2.52M-
Operating Expense
$ -2.04M$ 27.66M$ 19.87M
Operating Income
$ -9.14M$ -25.14M$ -19.87M
Net Non Operating Interest Income Expense
$ -3.77M$ 3.89M$ -5.08M
Other Income Expense
$ 1.61M$ 3.88M$ -4.19M
Pretax Income
$ -13.10M$ -25.12M$ -29.15M
Tax Provision
$ 175.16K$ 175.16K-
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -13.15M$ -25.09M$ -29.89M
Basic EPS
$ -14.38$ -11.62$ -29.60
Diluted EPS
$ -8.19$ -11.62$ -29.60
Basic Average Shares
$ 7.42M$ 2.16M$ 1.01M
Diluted Average Shares
$ 5.26M$ 2.16M$ 1.01M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ -2.04M$ 27.66M$ 19.87M
Net Income From Continuing And Discontinued Operation
$ -19.78M$ -25.09M$ -29.08M
Normalized Income
$ -12.88M-$ -28.32M
Interest Expense
$ 4.86K-$ 1.30M
$ -14.18M$ -25.01M$ -27.85M
$ -14.18M$ -25.01M$ -27.85M
Currency in USD

Ensysce Biosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis